Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

BACKGROUND: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ERJ Open Res
Auteurs principaux: Iseli, Thomas, Berghmans, Thierry, Glatzer, Markus, Rittmeyer, Achim, Massard, Gilbert, Durieux, Valérie, Buchsbaum, Thomas, Putora, Paul Martin
Format: Artigo
Langue:Inglês
Publié: European Respiratory Society 2020
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487347/
https://ncbi.nlm.nih.gov/pubmed/32963993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00010-2020
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires